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Abstract
Background:  Evidence-based clinical practice guidelines support clinical decision-making by making
recommendations to guide clinical practice. These recommendations are developed by integrating the expertise
of a multidisciplinary group of clinicians with the perspectives of consumers and the best available research
evidence. However studies have raised concerns about the quality of guideline development, and particularly the
link between research and recommendations. The reasons why guideline developers are not following the
established development methods are not clear.
We aimed to explore the barriers to developing evidence-based guidelines in eleven hospitals in Australia,
Indonesia, Malaysia, the Philippines and Thailand, so as to better understand how evidence-based guideline
development could be facilitated in these settings. The research aimed to identify the value clinicians place on
guidelines, what clinicians want in guidelines developed in hospital settings and what factors limit rigorous
evidence-based guideline development in these settings.
Methods: Semi-structured, face-to-face interviews were undertaken with senior and junior healthcare providers
(nurses, midwives, doctors, allied health) from the maternal and neonatal services of the eleven participating
hospitals. Interviews were audio-recorded, transcribed and a thematic analysis undertaken.
Results: Ninety-three individual, 25 pair and eleven group interviews were conducted. Participants were clear
that they want guidelines that are based on evidence and updated regularly. They were also clear that there are
major barriers to this. Most of the barriers were shared across countries, and included lack of time, lack of skills
in finding, appraising and interpreting evidence, lack of access to relevant evidence and difficulty arranging meetings
and achieving consensus.
Barriers that were primarily identified in Australian hospitals include cumbersome organisational processes and a
feeling that guidelines are being developed for bureaucratic ends. Barriers that were primarily identified in South
East Asian hospitals include difficulty accessing evidence due to limited resources available for computers, internet
and journal subscriptions and limited skills in computing and English.
Conclusions: The clinicians in these eleven very different hospitals want evidence-based guidelines. However
they are frustrated by guideline development processes that are enormously time, skill and resource intensive.
They feel strongly that "there's got to be a better way".
The fact that the great majority of the identified barriers were shared across settings may provide an opportunity 
to develop a more pragmatic way of developing guidelines that can be applied in many contexts.
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Background
Evidence-based clinical practice guidelines (EBCPGs) sup-
port clinical decision-making by integrating the expertise
of a multidisciplinary group of clinicians with the per-
spectives of consumers and the best available research evi-
dence, to make recommendations to guide clinical
practice.
As part of the move towards evidence-based health care,
health organisations and clinician groups are increasingly
required to develop and implement EBCPGs. There is
some evidence to support the role of EBCPGs, with
research demonstrating that in some situations, with rig-
orous development and thorough implementation,
EBCPGs can improve both the quality and outcomes of
care[1]
There are several guides to EBCPG development [2-7] and
there is broad agreement among these guides on the key
elements of the EBCPG development process[8] Despite
this, EBCPGs are often not developed in a reliable way,
and there is frequently very little link between the research
included in EBCPGs and their recommendations [9-13]
Existing methods of EBCPG development have largely
been produced at a national or international level, for use
by organisations creating EBCPGs to guide widespread
practice. The processes they describe often take years and
hundreds of thousands of dollars to complete. This
amount of time and money is not usually available in hos-
pital settings, and so there are immediate significant bar-
riers to EBCPG development at this level.
We undertook a needs analysis to explore the experience
of guideline development and the enablers of and barriers
to developing evidence-based guidelines in perinatal units
in hospitals in Australia, Indonesia, Malaysia, the Philip-
pines and Thailand, so as to better understand how evi-
dence-based guideline development could be facilitated
in these settings, and to explore how barriers to the devel-
opment EBCPGs varied between settings.
Methods
The research aimed to address three questions:
• What value do clinicians give evidence-based clinical
practice guidelines in hospital settings?
￿ What do clinicians want in evidence-based clinical
practice guidelines developed in a hospital setting?
￿ What factors limit rigorous evidence-based clinical
practice guideline development in hospital settings?
To address these questions, we undertook a needs assess-
ment using qualitative research methods, based on semi-
structured, face-to-face interviews with clinicians from the
maternal and neonatal services in two hospitals in each of
Australia, Indonesia, Malaysia and the Philippines and
three hospitals in Thailand. Both rural and metropolitan
hospitals were included. The hospitals in South East Asia
were participating in the SEA-ORCHID Project [14]
(South East Asia - Optimising Reproductive and Child
Health In Developing countries, http://
www.seaorchid.org) which aimed to improve the quality
of maternal and neonatal health care by increasing the
generation, synthesis and use of health research. The exist-
ing low levels of evidence-based clinical practice guideline
development and barriers to development specific to
these hospitals have been reported previously [15,16].
The two Australian hospitals were included to facilitate
investigation of the degree to which the barriers at the
hospitals in South East Asia were shared beyond this
region and to enable exploration of the experiences of
staff at a large metropolitan tertiary teaching hospital as
well as a smaller rural hospital.
At each hospital we aimed to interview two junior and two
senior doctors, and two junior and two senior nurses or
midwives, and appropriate allied health staff. Senior per-
sonnel working in the hospitals were asked to identify
potential participants. Potential participants received a
written explanatory statement and signed a consent form
to indicate informed consent. Ethics approval was granted
by Monash University and the appropriate ethics commit-
tees in the countries of the participating hospitals.
Interviews were loosely based on a pre-specified interview
protocol (see Additional file 1), but the specific questions
were varied according to the level of experience and previ-
ous responses of the interviewees. Participants were asked
to describe the process for developing guidelines at their
hospital, the barriers to development of evidence-based
guidelines and how they thought guidelines should be
developed. The interview protocol was piloted at two hos-
pitals and then slightly revised for use in the other hospi-
tals. In South East Asia the questions about guidelines
formed part of a larger interview about evidence-based
practice, in Australia the interviews focused specifically on
guidelines.
Interpreters were used for the interviews where required.
Interviews were audio recorded, de-identified and tran-
scribed, and the data coded and then analysed in emerg-
ing themes using NVivo software. A subset of the data was
independently coded by a second reviewer to confirm
analysis.
Results
Ninety-three individual, 25 pair and eleven group inter-
views were conducted. Fifty-three participants were inter-
viewed in Thailand, 68 in Malaysia, 27 in Indonesia, 31 inBMC Health Services Research 2009, 9:235 http://www.biomedcentral.com/1472-6963/9/235
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the Philippines and 18 in Australia. Doctors and either
nurses or midwives or both were interviewed at all sites.
Allied health staff were only interviewed in Australia. All
participating nurses/midwives and allied health staff were
female. Both male and female doctors were interviewed at
all sites. Male doctors represented approximately 30% of
all doctors interviewed and were more common in senior
positions and neonatal specialties. At each of the sites, the
final interviews did not generate any new themes.
The interviews highlighted several themes including the
value of and need for guidelines and the requirement for
guidelines to be evidence-based, concise and clinically
focused, credible, multidisciplinary and up-to-date. They
also identified several barriers to development of guide-
lines, including lack of time, lack of skills, lack of access to
evidence, difficulty arranging meetings and achieving con-
sensus, and the role of adaptation of guidelines. A sum-
mary of the key points of these results is provided in
Additional file 2.
Results are presented in these emerging themes with direct
quotes (in italics) to illustrate concepts.
The value of and need for guidelines
All participants agreed that there was a need for guidelines
to support clinical practice. Guidelines were seen as
important in providing guidance about best practice and
supporting standardisation of practice. Participants
thought guidelines were particularly useful for new or jun-
ior staff, and for infrequently performed practices.
"I think that they're important and I think that we need them,
because we need direction and we need consistency in our care."
Senior Nurse, Australia, Female.
However, there was a feeling among several participants
from Australia that health services and clinicians were
becoming over-reliant on guidelines or that guidelines
were being seen as a panacea. Participants were concerned
that guidelines were being developed as an unthinking
reaction in clinical areas that were well understood rather
than in areas of controversy or variation in practice where
they would be more useful. Participants suggested that it
might be more beneficial to focus on developing major
guidelines in critical areas of clinical practice.
"Because if something goes wrong once, there's an immediate
thing 'Right, well we must have a guideline'. This reflex that we
must have a guideline or we must change the guideline, I think
is an inappropriate reflex." Senior Doctor, Australia, Female.
While supportive of guidelines in principle, several senior
Australian participants were very concerned that guide-
lines were increasingly being developed to meet bureau-
cratic or reporting requirements, rather than to support
clinical practice and that, as a result, they were becoming
"notoriously useless" Senior Doctor, Australia, Male.
These participants emphasised that if guidelines are to be
useful they must be written by clinicians, to meet the
needs of clinicians rather than administrators.
"I've become more and more disenchanted with the preparation
of clinical guidelines ... because I get the sense that clinical
practice guidelines in my hospital are written for administrators
and for key performance indicators for the [government]." Sen-
ior Doctor, Australia, Male.
Some clinicians in each of the countries expressed doubts
about whether guidelines were being used.
Q: "Do you think guidelines are useful?"
A: "It is useful ...if most of us read them."
Q: "Do you think they are used?"
A: "I don't think so." Senior Doctor, Malaysia, Male.
The requirements for guidelines
Participants provided strong direction about what they
needed in guidelines.
Evidence-based
All the participants were very clear that guidelines must be
based on the best available research evidence if they are to
be useful. They felt strongly that evidence should be used
to ensure the guidelines are accurate and reliable, not only
to ensure best practice but also to provide support in case
of legal action.
"Well if they're not based on evidence, who is saying it's the
right way to do it?. If all the evidence says you should do it this
way and this hospital decides to do it that way, from a medico-
legal perspective it can't be very good." Senior Nurse, Australia,
Female.
In all hospitals, participants noted that most locally-
developed guidelines were not developed in a rigorously
evidence-based manner.
"In house [guidelines are] just handed down from colleague to
colleague and not evidence-based necessarily, but just current
practice and what works and maybe what other hospitals do
locally, but nothing really technically evidence-based." Allied
Health Clinician, Australia, Female.
Concise and clinically focused
The key message about the format of guidelines was that
they should be clear, well-written, short and provide a
quick answer to clinical decision of interest. ParticipantsBMC Health Services Research 2009, 9:235 http://www.biomedcentral.com/1472-6963/9/235
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often suggested that a logical, step-by-step progression
was important and that algorithms or flowcharts were use-
ful.
Many Australian participants were deeply frustrated by
guidelines in which the clinically relevant information
was preceded by several pages of what they perceived as
less important information about organisational require-
ments or administrative processes. Clinicians wanted the
key clinical recommendations to be presented at the front
of the guideline.
"I find that often the information that you want is towards the
end of it and it can be very long-winded and stuff that you don't
need and ... especially if you're in emergency ... and you really
need to find out something, it's not that easy to find." Junior
Nurse, Australia, Female.
Two very different thoughts were expressed by interview-
ees about the ideal format of guidelines: that they must be
simple and quick to read and that they should be detailed
and thorough. Many participants felt that a flowchart or
algorithm alone was not enough, and that these should be
followed by more detailed information explaining the
reasoning behind the recommendations of the guideline
and providing links to the original papers from which the
evidence was drawn.
"I quite like structures where the guideline exists in several lay-
ers. There's a very simple layer which is your day to day decision
making where you don't necessarily even want to understand
what underpins it. But you can dig deeper and deeper as you
wish to do, particularly if you're faced with a point in the guide-
line that you're struggling to accept that it does actually apply
to the clinical situation where you actually really do go back and
say, 'okay, well what was the evidence at that point?"' Senior
Doctor, Australia, Male.
Credible
Participants wanted credible guidelines, with recommen-
dations that were trustworthy. Assessment of the credibil-
ity of a guideline was based on a number of factors
including respect for the developing organisation,
approval of the guideline by the health service and clarity
of the development methods, including clear searches for
research evidence, broad consultation and piloting of the
guideline.
"I think it probably gets back to the process of how the guideline
was formulated, so if it has been consultative, if there's been
some evidence to support it or not support it. And then if it is
trialled for a certain period of time." Allied Health Clinician,
Australia, Female.
Multidisciplinary
In Australia there was variation between senior and junior
participants about whether guideline development
should involve clinicians from across disciplines. All sen-
ior doctors and nurses, and most allied health profession-
als felt that it was essential that guideline development
should be multidisciplinary, should involve both junior
and senior staff, and that there should be wide consulta-
tion. Some junior doctors and nurses agreed, however sev-
eral were surprised that multidisciplinary guideline
development would be undertaken and were unclear
about the value of input from clinicians from other disci-
plines.
"I imagine that the nurses and physiotherapists and audiolo-
gists, they do have their guidelines. I can't see why a medical
person would have to have too much input into development of
that." Junior Doctor, Australia, Male.
In most of the hospitals in South East Asia, having a multi-
disciplinary group responsible for guideline develop-
ment, as is recommended by evidence-based guideline
development methods, was not usual practice, nor was it
explicitly valued. Most often the guidelines were largely
developed by the senior medical staff.
Q: "Are nurses involved in writing the protocols?"
A: "No. Consultants. Consultants and the specialists they are
the ones who go in a closed room I think. ... Then they come up
with the protocol." Senior Nurse, Malaysia, Female.
However in some hospitals this was not the case, or was
beginning to change and involvement of nurses and mid-
wives in some aspects of the guideline development proc-
ess was felt to be valuable.
"Actually when we make the guidelines we invite the midwives
to give their opinion, when like we're brainstorming..., the mid-
wives give their questions too. And it's very important..." Senior
Doctor, Indonesia, Female.
Most participants in both Australia and South East Asia
were unconvinced that consumer involvement in guide-
line development was important. They felt that while
involving consumers in guideline development was
potentially useful in some situations, it was not essential,
particularly in technical areas, and it could create prob-
lems if consumers had difficulty understanding the con-
cepts or could not remove themselves from their personal
experience, so as to provide broader input.
"To be honest I struggle to see where the value is, but I'd be will-
ing to be convinced." Senior Doctor, Australia, Male.BMC Health Services Research 2009, 9:235 http://www.biomedcentral.com/1472-6963/9/235
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Up-to-date
Participants from all settings were very clear that guide-
lines need to be kept up-to-date. They suggested that
guidelines should have expiry dates and that there should
be a process of regular review when searches for addi-
tional evidence were undertaken. Several suggested that
this review should be annual.
"It would have to be a fluid document that could be changed as
knowledge was gained. Because that is the problem with a lot
of these things. They get done, but they don't get updated."
Allied Health, Australia, Female.
The barriers to development of guidelines
The participants were very clear that there were some
major barriers to development of guidelines to meet the
needs they identified, and that as a result, these needs
were not currently being met.
Lack of time
Unsurprisingly, the most frequently mentioned barrier to
guideline development in all settings was time. Partici-
pants noted that rigorous guideline development takes
many months and believed that neither they nor their
staff or colleagues had the time to develop guidelines in
methodologically rigorous ways. Participants emphasised
that it was very difficult to quarantine or prioritise time for
activities like guideline development when there were
already enormous clinical pressures on their time.
"There's just not enough time. We're busy enough as it is caring
on the floor let alone being allotted the time to develop these
guidelines." Senior Nurse, Australia, Female.
In Australia, several participants suggested that one of the
reasons for the time-consuming nature of guideline devel-
opment was the process required to obtain organisational
approval for guidelines, particularly when the committees
involved met only infrequently.
The long time periods required to ensure broad consulta-
tion were another frequently mentioned reason for the
substantial time required to develop guidelines.
Lack of skills
A lack of the skills required to develop guidelines in the
local clinical environment was a commonly mentioned
barrier. In Australia, participants perceived a lack of high-
level skills in finding, appraising and interpreting research
evidence, as well as in writing the guideline documents.
Although several participants had experience in some of
these aspects, few were confident that they or their col-
leagues had the level of these skills required to develop
reliable evidence-based guidelines.
Q: "In this unit, does your team have the skills that they need
to, if time wasn't an issue?"
A: "Well the obvious answer to that is no." Senior Doctor, Aus-
tralia, Male.
Participants, and particularly nurses, in South East Asia
frequently noted that lack of skill in English and lack of
skill in using computers and the internet limited their
ability to search for evidence
"I do this ... search from website Cochrane Library but I have
the problem with English, it's a little bit difficult for me to
read." Junior Nurse, Indonesia, Female.
Lack of access to evidence
As well as limited skills in finding evidence, participants
also noted that for some clinical areas there was no evi-
dence available on which to base guideline recommenda-
tions. In Australia, this was mentioned as a barrier to
guideline development both in situations where evidence
would be useful, but trials had not yet been conducted,
and also in situations whose nature meant that trials
would never be undertaken.
In South East Asia, interviewees were also limited in their
ability to find and use research evidence because of limi-
tations on availability of computers, internet access and
full text journal articles.
"We have internet access here, but our computer is non-func-
tional right now. ... we're using only one for about 50 people
actually." Junior Doctor, The Philippines, Female.
Difficulty arranging meetings and achieving consensus
Another barrier common to all settings was that guideline
development meetings with broad representation were
hard to organise.
"So if you want to meet with the four of us, it's almost impossi-
ble to have everybody free at one time. We can make a mini-
mum of three, but ... it's so difficult actually, sometimes they
have something on, and then we have something on, and it gets
postponed. And it dies off." Senior Doctor, Malaysia, Male.
The process of achieving consensus on the recommenda-
tions of the guideline was felt to be very important, espe-
cially in terms of enabling the implementation of the
guideline, but also a potential barrier to development if
agreement could not be reached.
A: "In our case, we are stopping the guidelines because there
have been some problems ..."
Q: "So you've had to stop for a while, is it for clinical reasons?
Because you were too busy or?"BMC Health Services Research 2009, 9:235 http://www.biomedcentral.com/1472-6963/9/235
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A: "No, not the clinical reason [laughs]...I think it's more on
conflicting ideas". Junior Doctor, The Philippines, Female.
There was also a concern among Australian participants
that consensus processes were too easily dominated by
more confident group members. Participants were con-
cerned that nurses and more junior staff were less likely to
feel comfortable to be assertive and contribute their per-
spectives, particularly if these were in conflict with views
expressed by others. This was tempered by suggestions
that they might become more comfortable if they had
more experience in these situations.
The role of adaptation
Participants also talked about adapting guidelines from
other hospitals or organisations for use in their own set-
tings. While participants from all settings were generally
positive about this approach, there were different levels of
acceptance, with several participants suggesting that they
would look at other guidelines to get background infor-
mation or to confirm that local practice was in line with
that recommended elsewhere, but that they didn't feel it
was appropriate to use them directly.
Participants from all countries were concerned about both
the relevance of externally developed guidelines to their
clinical setting and also the lack of high-quality guide-
lines.
Discussion
This research highlights that while guidelines are valued,
there are major barriers to developing EBCPGs in hospi-
tals. These include lack of time, skills, information tech-
nology (IT) infrastructure and access to research. These
barriers reflect and build on those identified by other
researchers.
Lack of time and skills have also been identified as barriers
to EBCPG development by national professional bodies
[17-19]. It has been suggested that the substantial time
and skills required to undertake systematic reviews for
EBCPG development have led some professional groups
to revert to consensus-based CPG development [19]. Of
particular importance to EBCPG development in hospital
contexts is that skills in systematic reviewing of research
literature are not commonly part of the training of clini-
cians and these skills are unlikely to be available to hospi-
tals who seek to develop EBCPGs [20,21].
Previous research has established that IT resources are a
basic requirement for finding and using research and that
these are often not available in resource-poor settings
[22,23]. The importance of access to research, in the form
of subscriptions to journals, research databases and simi-
lar resources, to enable improvement in health care deliv-
ery has similarly been recognised in other studies [23,24].
Awareness of these barriers to developing EBCPGs has led
to a call for more feasible methods of developing guide-
lines that balance rigour and pragmatism, and for research
to examine "the trade-off between rigor and pragmatism that
currently challenges the guideline movement." [19] Some
authors have suggested that EBCPG development should
be undertaken by methodologists rather than by clinical
experts [25]. This approach would address two of the bar-
riers identified in this study; clinicians would not have to
be experts in systematic reviewing, nor find time above
their clinical load to develop EBCPGs. However, develop-
ment of EBCPGs led by methodologists would rely on
availability of methodologists and funding, and this is
unlikely to be achieved in hospitals.
This study has some limitations. The relatively small
number of hospitals included limits the extent to which
the results can be applied to other settings. However the
hospitals were very diverse, including both rural and met-
ropolitan environments in a high-income country and a
variety of low and middle income countries. The consist-
ency of the results reported across these hospitals suggests
that the results may be applicable beyond the settings in
which the research was conducted.
Similarly, the interviews were all undertaken in maternal
and neonatal healthcare settings and so the results may
not be generalisable to other clinical areas. However the
substantial gap between research and practice and the
resulting rates of preventable maternal and child morbid-
ity and mortality, particularly in Asia and the Pacific
where these studies were undertaken, make maternal and
neonatal healthcare a priority for research [26].
Further research is required to determine the extent to
which the results of this study reflect the value placed on,
and experience of, EBCPG development in other contexts
and clinical areas. Research is also required to develop
pragmatic EBCPG development methods that are feasible
in hospital settings and which produce guidelines which
are trustworthy.
Conclusions
The clinicians in these eleven very different hospitals all
value guidelines and want EBCPGs that provide rapid
access to reliable, up-to-date information to help them
make the best possible decisions. However they feel that
established EBCPG development processes that are enor-
mously time, skill and resource intensive, are not feasible
in their settings. They feel strongly that a more feasible
way of developing guidelines, or of getting evidence into
practice, is needed.
Most of the barriers to evidence-based guideline develop-
ment identified by these participants were shared across
all hospitals, however there were a few that were specificBMC Health Services Research 2009, 9:235 http://www.biomedcentral.com/1472-6963/9/235
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to particular contexts. The fact that the great majority of
the identified barriers were shared across settings may
provide an opportunity to develop a more pragmatic way
of developing guidelines that can be applied in many con-
texts, with awareness of the specific additional barriers
that are relevant in particular settings.
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Table 1. Table displaying the indicative questions used in the study.




Table 2. A list of key points from the study.
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